首页> 美国卫生研究院文献>Endocrinology Diabetes Metabolism Case Reports >Lessons learnt from a case of missed central hypothyroidism
【2h】

Lessons learnt from a case of missed central hypothyroidism

机译:从中枢性甲状腺功能低下的案例中吸取的教训

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We present the case of a 57-year-old lady who had a delayed diagnosis of central hypothyroidism on a background of Grave’s thyrotoxicosis and a partial thyroidectomy. During the twenty years following her partial thyroidectomy, the patient developed a constellation of symptoms and new diagnoses, which were investigated by numerous specialists from various fields, namely rheumatology, renal and respiratory. She developed significantly impaired renal function and raised creatine kinase (CK). She was also referred to a tertiary neurology service for investigation of myositis, which resulted in inconclusive muscle biopsies. Recurrently normal TSH results reassured clinicians that this did not relate to previous thyroid dysfunction. In 2015, she developed increased shortness of breath and was found to have a significant pericardial effusion. The clinical biochemist reviewed this lady’s blood results and elected to add on a free T4 (fT4) and free T3 (fT3), which were found to be <0.4 pmol/L (normal range (NR): 12–22 pmol/L) and 0.3 pmol/L (NR: 3.1–6.8 pmol/L), respectively. She was referred urgently to the endocrine services and commenced on Levothyroxine replacement for profound central hypothyroidism. Her other pituitary hormones and MRI were normal. In the following year, her eGFR and CK normalised, and her myositis symptoms, breathlessness and pericardial effusion resolved. One year following initiation of Levothyroxine, her fT4 and fT3 were in the normal range for the first time. This case highlights the pitfalls of relying purely on TSH for excluding hypothyroidism and the devastating effect the delay in diagnosis had upon this patient.Learning points: class="unordered" style="list-style-type:disc">Isolated central hypothyroidism is very rare, but should be considered irrespective of previous thyroid disorders.If clinicians have a strong suspicion that a patient may have hypothyroidism despite normal TSH, they should ensure they measure fT3 and fT4.Laboratories that do not perform fT3 and fT4 routinely should review advice sent to requesting clinicians to include a statement explaining that a normal TSH excludes primary but not secondary hypothyroidism.Thyroid function tests should be performed routinely in patients presenting with renal impairment or a raised CK. class="head no_bottom_margin" id="__sec2title">BackgroundCentral hypothyroidisim is rare with an incidence of 1 in 80 000–120 000 individuals (). It is characterised by insufficient thyroid gland stimulation by TSH, resulting from hypothalamic or pituitary dysfunction. It is rarely isolated and occurs more commonly in conjunction with other pituitary hormone deficiencies, as well as neurological symptoms and signs resulting from the causative lesion. Symptoms tend to be similar to primary thyroid dysfunction, but according to the literature may be milder ().In adults, the commonest causes are pituitary macroadenomas, pituitary surgery or irradiation (), but there are increasing examples of genetic causes causing isolated central thyroid dysfunction.With the use of serum TSH as an initial screening test for thyroid dysfunction, the diagnosis of central hypothyroidism may be delayed or even missed because most of these patients have normal or low TSH. Hence, many guidelines, including the British Thyroid Association, suggest that ‘if laboratories are unable to identify those specimens that specifically require the measurement of both serum TSH and fT4, then it would be prudent to measure serum TSH and fT4 on all specimens rather than embark on a first-line serum TSH strategy’. They suggest that ‘Measurement of serum TSH alone is appropriate after the first investigation in the sequential follow-up of individuals who have not been treated for thyroid disorders and who may be at risk of developing thyroid dysfunction’ ().Reporting of cases like this is important in order to raise awareness of this condition to general practitioners and other physicians who may be falsely reassured by a normal TSH result. As a result of this case, our biochemistry department has changed its advice to GPs about what to do in the case of a normal TSH : ‘TSH within limits excludes primary (but not secondary) hypothyroidism. If there is high clinical suspicion of hypothyroidism, please contact laboratory clinical staff to discuss further tests’.
机译:我们介绍了一位57岁的女士,她在Grave的甲状腺毒症和部分甲状腺切除术的背景下,诊断出迟发的中央性甲状腺功能减退症。在甲状腺部分切除术后的20年中,患者出现了一系列症状和新诊断,风湿病学,肾脏和呼吸系统各个领域的众多专家对此进行了调查。她的肾功能明显受损,肌酸激酶(CK)升高。她还被转诊至第三级神经内科,以调查肌炎,导致肌肉活检结果不确定。 TSH结果恢复正常后,临床医生可以放心,这与以前的甲状腺功能障碍无关。 2015年,她出现了呼吸急促,并发现了明显的心包积液。临床生物化学家检查了这位女士的血液检查结果,并选择添加游离T4(fT4)和游离T3(fT3),发现游离T4(fT4)和游离T3(fT3)(<正常范围(NR):12–22 pmol / L)和0.3µpmol / L(NR:3.1–6.8µpmol / L)。她被紧急转诊至内分泌服务部门,并开始使用左甲状腺素替代治疗,以治疗严重的中央甲状腺功能减退症。她的其他垂体激素和MRI检查均正常。次年,她的eGFR和CK恢复正常,肌炎症状,呼吸困难和心包积液消失。左甲状腺素开始使用一年后,她的fT4和fT3首次处于正常范围。该病例突出了单纯依靠TSH排除甲状腺功能减退症的陷阱以及延误诊断对该患者的破坏性影响。学习要点: class =“ unordered” style =“ list-style-type:disc”> <! -list-behavior =无序前缀-word = mark-type = disc max-label-size = 0-> 孤立的中央性甲状腺功能减退症非常少见,但无论以前是否患有甲状腺疾病,都应予以考虑。 如果临床医生强烈怀疑尽管TSH正常,患者仍可能患有甲状腺功能减退症,则应确保他们测量fT3和fT4。 常规不执行fT3和fT4的实验室应查看发送给请求者的建议临床医生应包括一条说明,说明正常的TSH排除了原发性甲状腺功能减退症,但不包括继发性甲状腺功能减退症。 对肾功能不全或CK升高的患者应常规进行甲状腺功能检查。 class =“ head no_bottom_margin” id =“ __ sec2title”>背景中央虚伪hyroidisim很少见,每80 000至120 000个人中有1人发病()。其特征是下丘脑或垂体功能障碍导致TSH对甲状腺的刺激不足。它很少被隔离,并且更常见地与其他垂体激素缺乏症以及由病因引起的神经系统症状和体征结合在一起发生。症状往往与原发性甲状腺功能异常相似,但根据文献报道可能较轻()。在成年人中,最常见的原因是垂体大腺瘤,垂体手术或放射线(),但有遗传原因导致孤立的甲状腺中枢的例子增多功能障碍:使用血清TSH作为甲状腺功能障碍的初步筛查试验,由于大多数这些患者的TSH正常或较低,因此中枢性甲状腺功能减退症的诊断可能会延迟甚至错过。因此,包括英国甲状腺协会在内的许多指南都建议:“如果实验室无法鉴定出那些特别需要同时测定血清TSH和fT4的标本,那么就应该对所有标本进行血清TSH和fT4的测定,而不是对它们进行测定。开展一线血清TSH策略”。他们建议:``在对未接受甲状腺疾病治疗且可能有发展甲状腺功能障碍风险的个体进行连续随访的首次随访后,单独进行血清TSH的测定是适当的''()。重要的是要提高全科医生和其他医师对这种情况的认识,而普通医师和其他医师可能会因正常TSH结果错误地放心。由于这种情况,我们的生物化学部门已更改了向全科医生提供的有关正常TSH情况下的建议:‘TSH在一定范围内不包括原发性(而非继发性)甲状腺功能减退症。如果临床高度怀疑甲状腺功能减退,请联系实验室临床人员讨论进一步的检查。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号